RCC mortality in Brazil demonstrates age- and region-specific heterogeneity at the population level, and surgical data reveal persistent disparities in access to oncological surgical treatment within the public sector.
Abstract
Abstract Objectives Renal cell carcinoma represents a growing global health challenge, characterized by rising incidence rates and high mortality associated with late-stage detection. In Brazil, the asymptomatic nature of early-stage disease and the lack of routine screening frequently delay diagnoses, while population-based data on disparities in surgical access remain limited. This study aims to describe parallel national trends in renal cell carcinoma (RCC) mortality and public-sector surgical delivery patterns in Brazil between 2013 and 2023, and to assess demographic and regional disparities. Methods This nationwide ecological study analyzed secondary data from two Brazilian administrative databases: the Mortality Information System (SIM) and the Hospital Information System of the Unified Health System (SIH/SUS). Age-standardized mortality rates were calculated using population estimates from the Brazilian Institute of Geography and Statistics (IBGE). Temporal trends were assessed using Joinpoint regression to estimate Annual Percent Change (APC). Surgical data were analyzed descriptively to evaluate procedure volume and modality distribution within the public health system. Results Between 2013 and 2023, a total of 70,588 renal surgeries were performed within SUS, of which approximately 33,000 were oncological nephrectomies. Among all renal surgeries, radical procedures predominated (92.2 %), while partial nephrectomies accounted for only 7.8 % of the total volume. In the oncological subset, which reached 4,277 annual procedures by 2023, radical techniques accounted for 63.6 % of cases and partial nephrectomies 36.4 %. Mortality analysis demonstrated significant increases among individuals aged ≥80 years in both sexes, whereas middle-aged groups (60–79 years) showed initial increases followed by stabilization. Regional disparities were observed in surgical rates, with the Northeast recording the lowest rate (18.34 per 100,000 inhabitants/year) and the South the highest (48.56 per 100,000 inhabitants/year). Conclusions RCC mortality in Brazil demonstrates age- and region-specific heterogeneity at the population level. Surgical data reveal persistent disparities in access to oncological surgical treatment within the public sector. These findings provide complementary system-level indicators of cancer burden and distribution of healthcare infrastructure, highlighting areas for policy intervention and improvements in national data integration.
PC mortality in Brazil has risen significantly over the past four decades, with marked regional and sex-specific disparities, aligning with global perspectives, and the need for targeted PC prevention, early detection, and equitable access to high-quality cancer care is highlighted.
Lucas Casagrande Passoni Lopes, Isabela Ussifati Negrine, Carlos Antonio Negrato· Arquivos de Gastroenterologi...· 0 citations
Background: Pancreatic Cancer is the sixth deadliest cancer across the world, and its incidence has more than doubled in recent decades. The literature lacks comprehensive evidence on rural-urban and place-of-death mortality trends over the last two decades. This retrospective analysis summarizes the mortality trends for deaths involving pancreatic cancer patients from 1999 to 2023, with urban and rural stratification to better direct interventional strategies.
Methods: Data from death certificates were extracted using the CDC WONDER database's multiple cause-of-death model, using ICD-10 codes C25.0 to C25.4 and C25.7 to C25.9 for adults aged 25+ years from 1999 to 2023. The urbanization data were extracted from 1999 to 2020. Urbanization regions were organized, and age-adjusted mortality rates (AAMRs) were calculated per 100,000 population. Joinpoint software was used for evaluating trends.
Results: A total of 1,002,439 deaths from pancreatic cancer occurred from 1999 to 2023, with an overall increase in AAMR from 17.254 in 1999 to 18.446 in 2023 (AAPC: 0.3293%). The death rate in rural areas, though declining initially (APC: -0.2572%), has increased persistently since 2003 (APC: 0.773%), surpassing the urban death rate from 2010 onwards. The rise in urban fatality rates was less steep (AAPC: 0.20%). Place of death was analyzed as a cross-period distribution, with the majority of deaths occurring in the decedent’s home (48.3%), followed by medical facilities (25.19%) and nursing homes (11.26%).
Conclusion: A consistent rise in pancreatic cancer-related mortality with an increasing trend for rural areas emphasizes the discrepancy and the possible need for targeted interventions.
Zuha Tariq, Alyaa Ahmed Ibrahim, Ahmed Khairy et al.· ASIDE Oncology· 0 citations
The study revealed both advances and persistent gaps in oral cancer care in Ceará, underscoring the need for a specific observatory to improve monitoring and ensure comprehensive oncological care.
Jennifer Vianna Barbosa, Weslley Nilson Oliveira de Sousa, Janderson Fernando da Silva et al.· Revista Brasileira de Cancer...· 0 citations
Divergent trends between incidence and mortality likely reflect reduced detection during the pandemic rather than true changes in disease burden, and highlight the importance of maintaining continuity of cancer screening and diagnostic services during health-system disruptions.
Nomin-Erdene Tsogtgerel, Dolgorkhand Adiyadorj, Gan-Erdene Ganbaatar et al.· Frontiers in Oncology· 0 citations
The trends revealed a significant increase in incidence across all macro-regions, particularly in the North and South regions, whereas mortality rates remained stable, whereas mortality rates remained stable in the North and South regions.
Cristiane Maria da Costa-Silva, Higor Andrade de Oliveira Gonçalves, Ana Luísa Tavares de Oliveira et al.· Cancer Epidemiology· 0 citations